Exploring anti-IL6 receptor monoclonal antibody tocilizumab in neuromyelitis optica

被引：0
|
作者：
Araki, M. [1 ]
Matsuoka, T. [1 ]
Aranami, T. [1 ]
Nakamura, M. [1 ]
Okamoto, T. [1 ]
Murata, M. [1 ]
Miyake, S. [1 ]
Yamamura, T. [1 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：326 / 327
页数：2
相关论文
共 50 条
  • [21] ANTI-IL-6 RECEPTOR ANTIBODY (TOCILIZUMAB): A B CELL TARGETING THERAPY
    Toubi, E.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 152 - 152
  • [22] ANTI-IL-6 RECEPTOR ANTIBODY (TOCILIZUMAB): A B CELL TARGETING THERAPY
    Snir, A.
    Kessel, A.
    Haj, T.
    Rosner, I
    Rozenbaum, M.
    Slobodin, G.
    Toubi, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70
  • [23] Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy
    Snir, A.
    Kessel, A.
    Haj, T.
    Rosner, I.
    Slobodin, G.
    Toubi, E.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 697 - 700
  • [24] The effect of Neuromyelitis optica (NMO)-IgG and anti-IL-6 receptor monoclonal antibody (SA237; satralizumab) for barrier function at the Blood-Brain Barrier in vitro
    Takeshita, Y.
    Serizawa, K.
    Fujikawa, S.
    Shimizu, F.
    Maeda, T.
    Sano, Y.
    Koga, M.
    Kanda, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 208 - 209
  • [25] Intracellular Dynamics and Fate of a Humanized Anti-Interleukin-6 Receptor Monoclonal Antibody, Tocilizumab
    Fujimoto, Keiko
    Ida, Hiroaki
    Hirota, Yuko
    Ishigai, Masaki
    Amano, Jun
    Tanaka, Yoshitaka
    [J]. MOLECULAR PHARMACOLOGY, 2015, 88 (04) : 660 - 675
  • [26] Treatment Resistant Neuromyelitis Optica Responsive to Anti IL-6 Immunotherapy
    Siwoski, Mark-Victor
    Lynch, Sharon G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 120 - 120
  • [27] Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
    Imagawa, Tomoyuki
    Yokota, Shumpei
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Imanaka, Hiroyuki
    Nerome, Yasuhito
    Iwata, Naomi
    Murata, Takuji
    Miyoshi, Mari
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    [J]. MODERN RHEUMATOLOGY, 2012, 22 (01) : 109 - 115
  • [28] Long-term safety and efficacy of tocilizumab (an anti-IL-6 receptor monoclonal antibody) in monotherapy, in patients with rheumatoid arthritis
    Nishimoto, N.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Azuma, J.
    Kishimoto, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 122 - 122
  • [29] Anti-IL-6 receptor monoclonal antibody as a new treatment of endometriosis
    Ahmed A. El-Zayadi
    Sara A. Mohamed
    Mohammad Arafa
    Shereen M. Mohammed
    Abdelhady Zayed
    Mohamed S. Abdelhafez
    Ahmed M. Badawy
    [J]. Immunologic Research, 2020, 68 : 389 - 397
  • [30] Anti-IL-6 receptor monoclonal antibody as a new treatment of endometriosis
    El-Zayadi, Ahmed A.
    Mohamed, Sara A.
    Arafa, Mohammad
    Mohammed, Shereen M.
    Zayed, Abdelhady
    Abdelhafez, Mohamed S.
    Badawy, Ahmed M.
    [J]. IMMUNOLOGIC RESEARCH, 2020, 68 (06) : 389 - 397
12345